Hui Tao
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 4
- Pharmaceutical Science top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 10
- Immunology top 10%
- Immune cells in cancer 4
- Molecular Medicine top 10%
-
- Cardiac Health and Mental Health 7
- Heart Rate Variability and Autonomic Control 4
-
- Advanced Nanomaterials in Catalysis 4
-
- Membrane Separation Technologies 4
-
- Photodynamic Therapy Research Studies 4
- Journals
- Advanced Materials (1 paper)ACS Nano (2 papers)Journal of the American College of Cardiology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Hui Tao
36 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 129
- Biomaterials 320
- Pharmaceutical Science 99
- Biomedical Engineering 673
- Immunology 286
- Molecular Medicine 51
Countries citing papers authored by Hui Tao
This map shows the geographic impact of Hui Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Tao more than expected).
Fields of papers citing papers by Hui Tao
This network shows the impact of papers produced by Hui Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Tao. The network helps show where Hui Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 45 | |
| 16 | 2019 | 188 | |
| 17 | 2019 | 20 | |
| 18 | 2018 | 79 | |
| 19 | 2016 | 82 | |
| 20 | 2008 | 56 |
About Hui Tao
Hui Tao is a scholar working on Immunology, Complementary and Manual Therapy and Cardiology and Cardiovascular Medicine, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Cardiac Health and Mental Health (7 papers), Advanced Nanomaterials in Catalysis (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Heart Rate Variability and Autonomic Control (4 papers), Membrane Separation Technologies (4 papers), Photodynamic Therapy Research Studies (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Biomaterials (320 citations), Pharmaceutical Science (99 citations) and Biomedical Engineering (673 citations). Hui Tao has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Jianxiang Zhang, Houyuan Hu, Huijie An, Yin Dou, Xiaoqiu Xu, Lanlan Li, Xiaohui Li, Dinglin Zhang, Qixiong Zhang and Yi Jia. Their work appears in journals such as Advanced Materials, ACS Nano and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.